NPPB and Left atrial enlargement: Although there are several potential biomarkers indicative of atrial cardiopathy, PTFV1 (>5,000 μV* ms), NT-proBNP (>250 pg/ml), and left atrial enlargement are currently promising biomarkers for the diagnosis of atrial cardiopathy.